Observational study of haloperidol in hospitalized patients with COVID-19.

Observational study of haloperidol in hospitalized patients with COVID-19.

<h4>Background</h4>Haloperidol, a widely used antipsychotic, has been suggested as potentially useful for patients with COVID-19 on the grounds of its in-vitro antiviral effects against SARS-CoV-2, possibly through sigma-1 receptor antagonist effect.<h4>Methods</h4>We examine...

Full description

Bibliographic Details
Main Authors: Nicolas Hoertel, Marina Sánchez-Rico, Raphaël Vernet, Anne-Sophie Jannot, Antoine Neuraz, Carlos Blanco, Cédric Lemogne, Guillaume Airagnes, Nicolas Paris, Christel Daniel, Alexandre Gramfort, Guillaume Lemaitre, Mélodie Bernaux, Ali Bellamine, Nathanaël Beeker, Frédéric Limosin, AP-HP/Universities/INSERM Covid-19 research collaboration and AP-HP Covid CDR Initiative
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2021-01-01
Series:PLoS ONE
Online Access:https://doi.org/10.1371/journal.pone.0247122

Internet

https://doi.org/10.1371/journal.pone.0247122

Similar Items